Antigenic properties of fibrinogen component of Hemaseel™ HMN subjected to the antiviral severe dry heat treatment

Thrombosis Research

Volumn 82, Issue 4, 1996, Pages 349-359

  Cierniewski, Czeslaw S ^a   Pluskota, Elzbieta ^a   Cieslak, Marcin ^a   Brodniewicz, Teresa ^b   Nowotarski, Margaret ^b  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b Haemacure Corp   (Canada)

Author keywords

Fibrinogen glue; Heat treatment; Structure

Indexed keywords

FIBRIN GLUE; FIBRINOGEN;

ANTIGENICITY; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEAT SENSITIVITY; HUMAN; HYPERTHERMIC THERAPY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN STABILITY;

EPITOPES; FIBRIN TISSUE ADHESIVE; FIBRINOGEN; HEAT; HUMANS; PROTEIN CONFORMATION;

EID: 0030012634     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00084-9     Document Type: Article

References (44)

1. Hermans, J., McDonagh, J. Fibrin: structure and interactions. Thromb. Haemost. 8, 11-22, 1982.
2. Bruhn, H.D., Pohl, J. Growth regulation of fibroblast by thrombin, factor XIII and fibronectin. Klin. Wochenschr. 59, 145-146, 1981.
3. Grinnell, F., Feld, M.K. Initial adhesion of human fibroblasts in serum-free medium: possible role of secreted fibronectin. Cell 17, 117-129, 1979.
4. Tidrick, R.T., Warner, E.D. Fibrin fixation of skin transplants. Surgery 15, 90-95, 1944.
5. Cronkite, E.P., Lozner, E.L., Deaver, J.M. Use of thrombin and fibrinogen in skin grafting. JAMA 124, 976-978, 1944.
6. Ventura, R., Torri, G., Campari, A. Experimental suture of the peripheral nerves with "fibrin glue". Ital. J. Oethop. Traumatol. 6, 407-414, 1981.
7. Barton, B., Moore, E.E., Pearce, W.H. Fibrin glue as a biologic vascular patch - a comparative study. J. Surg. Res. 40, 510-513, 1986.
8. Jakob, H., Campbel. C.D., Stemberger, A. Combined application of heterologous collagen and fibrin sealant for liver injuries. J. Surg. Res. 36, 571-577, 1984.
9. Bergsland, J., Kalmbach, T., Balu, D. Fibrin seal - an alternative suture repair in experimental pulmonary surgery. J. Surg. Res. 40, 340-345, 1986.
10. Kram, H.B., Shoemaker, W.C., Hino, S.T. Splenic salvage using biologic glue. Arch. Surg. 119, 1309-1311, 1984.
11. Walterbush, G, Haverich, A., Borst, H.G. Clinical experience with fibrin glue for glue for local bleeding control and sealing of vascular prostheses. Thorac. Cardiovasc. Surg. 30, 234-235, 1982.
12. Hjortrup, A., Nordkild, P., Kiaergaard, J. Fibrin adhesive versus sutured anastomosis: a comparative intraindividual study in the small intestine of pigs. Br. J. Surg. 73, 760-761, 1986.
13. Tashiro, S., Murata, E., Hiraoka, T. New technique for pancreaticojenostomy using a biological adhesive. Br. J. Surg. 74, 387-394, 1987.
14. Glover, W., Chavis, T.V., Daniel, T.M. Fibrin glue application through the flexible fiberoptic bronchoscope: closure of bronchopleural fistulas. J. Thorac. Cardiovasc. Surg. 93, 470-472, 1987.
15. McCarthy, P.M., Trastek, V.F., Schaff, H.V. Esophagogastric anastomoses: the value of fibrin glue in preventing leakage. J. Thorac. Cardiovasc. Surg. 93, 234-239, 1987.
16. McCarthy, P.M., Trastek, V.F., Bell, D.G. The effectiveness of fibrin glue sealant for reducing experimental pulmonary leak. Ann. Thorac. Surg. 45, 203-205, 1988.
17. Woodward, S.C., Hermann, J.B., Leonard, F. (1964) Fed. Proc. 23, 495 (abstract).
18. Horowitz, M.S., Rooks, C., Horowitz, B. Virus safety of solvent/detergent-treated antihaemophilic factor concentrate. Lancet ii, 186-189, 1988.
19. Bunouf,-Radosevich, M., Duval, P., Burnouf, T. (1989). in: Stolts, J.F. (eds): Biotechnol. Plasma Proteins. Colloque INSERM 175, 89-100.
20. Berg, W.FV., tenCate, J.W., Breederveld, C. Seroconversion to HTLV-III haemophiliae given heat-treated factor VIII concentrate. Lancet i, 803-804, 1986.
21. Horowitz, B., Piet, M.P.J., Prince, A.F. Inactivation of lipid-enveloped viruses in labile blood derivatives by unsaturated fatty acids. Vox Sang 54, 14-20, 1988.
22. Pandya, B.V., Ciemiewski, C.S., Budzyński, A.Z. Conservation of human fibrinogen conformation after cleavage of the BB chain NH2 terminus. J. Biol. Chem. 260, 2994-3000, 1985.
23. Doolittle, R.F., Schubert, D., Schwartz, S.A. Amino acid sequence studies on artiodactyl fibrinopeptides. I.Dromedary camel.muledeer and cape buffalo. Arch. Biochem. Biophys. 118, 456-465, 1967.
24. Okude, M., Iwanaga, S. Carboxy-terminal residues of mammalian fibrinogen and fibrin. Biochim. Biophys. Acta 251, 185-196, 1971.
25. Chen, J.P., Shurley, H.M., Vickroy, M.F. A facile separation of fragments D and E from the fibrinogen-fibrin degradation products of three mammalian species. Biochem. Biophys. Res. Commun. 61, 66-71, 1974.
26. Cierniewski, C.S., Kłoczewiak, M., Budzyński, A.Z. Expression of primary polymeryzation sites in the D domain of human fibrinogen depends on intact conformation. J. Biol. Chem. 261, 9116-9121, 1986.
27. Ciemiewski, C.S., Budzynski, A.Z. Conformational equilibria in the chain COOH terminus of human fibrinogen. J. Biol. Chem. 262, 13896-13891, 1987.
28. Stocker, J.W., Malavasis, F., Trucco, M. (1981) in Immunological methods (Lefkovits, I., Benvenuto, P., eds) vol II, pp 299-308, Academic Press, London, New York, San Francisco.
29. Bradford, M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254, 1976.
30. Laemmli, U.K. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4 Nature 227, 680-685, 1970.
31. Towbin, H., Staehelin, T., Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocelulose sheet: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354, 1979.
32. Zar, J. (1984) Biostatistical Analysis, Prentice-Hall, Englewood Clifs, NJ.
33. Saltz, R., Sierra, D., Feldman, D., Bartczak, M., Dimick, A., Vasconez, L.O. Experimental and clinical applications of fibrin glue. Plastic Rec. Surg. 88, 1005-1015, 1991.
34. Eder, G., Neumann, M., Cerwenka, R. (1986) in: Schlag, G., Redl, H. (eds): Fibrin Sealant in operative medicine. Otortino-Laryngology. Heidelberg, Springer, vol. 1, 51-59.
35. White, G.C., Matthews, T.J., Weinhold, K.J. HTLV-III seroconversion associated with heat-treated factor VIII concentrate. Lancet i, 611-612, 1986.
36. Smith, J.K., Winkelman, L., Feldman, P.A. Interim results of surveillance for NANBH in patients receiving heated concentrates produced in England. Dev. Biol. Stand. 67, 323-325, 1987.
37. Bolton-Maggs, P.H.B., Wensley, R.T., Kernoff, P.B.A., Kasper, C.G., Winkelman, L., Lane, R.S., Smith, J.K. Production and therapeutic use of a factor XI concentrate from plasma. Thromb. Haemost. 67, 314-319, 1992.
38. Kowalska, M.A., Cierniewski, C.S. The intrinsic fluorescence of human fibrinogen and its fragments D and E. Thromb. Haemost. 48, 21-23, 1982.
39. Doolittle, R.F. Fibrinogen and fibrin. Annu. Rev. Biochem. 53, 195-229, 1984.
40. Fowler, W.E., Ericson, H.P. Trinodular structure of fibrinogen.Confirmation by both shadowing and negative stain electron microscopy. J. Mol. Biol. 134, 341-349, 1979.
41. Estis, L.F., Haschemeyer, R.H. Electron microscopy of negatively stained and unstained fibrinogen. Proc. Natl. Acad. Sci. USA 77, 3139-3143, 1980.
42. Telford, J.N., Nagy, J.A., Hatcher, P.A., Scheraga, H.A. Location of peptide fragments in the fibrinogen molecule by immunoelectron microscopy. Proc. Natl. Acad. Sci. USA 77, 2372-2376, 1980.
43. Cierniewski, C.S., Edgington, T.S. Internalization of the amino terminal 1-78 sequence of γ-chain of native fibrinogen and exposure associated with catabolism and Plasmin Cleavage. Biochim. Biophys. Acta 58, 32-43, 1979.
44. Cierniewski, C.S., Plow, E.F., Edgington, T.S. Conformation of the carboxy-terminal region of the Aa chain of fibrinogen as elucidated by immunochemical analyses. Eur. J. Biochem. 141, 489-496, 1984.